Cargando…
Effective Asthma Management: Is It Time to Let the AIR out of SABA?
For years, standard asthma treatment has included short acting beta agonists (SABA), including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for Asthma 2019 strategy for the management of asthma, the authors recommended a significant departure from the traditional tr...
Autores principales: | Kaplan, Alan, Mitchell, Patrick D., Cave, Andrew J., Gagnon, Remi, Foran, Vanessa, Ellis, Anne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230470/ https://www.ncbi.nlm.nih.gov/pubmed/32230875 http://dx.doi.org/10.3390/jcm9040921 |
Ejemplares similares
-
Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice
por: Ellis, Anne K., et al.
Publicado: (2022) -
The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription
por: Domingo, Christian, et al.
Publicado: (2023) -
SABAs as Reliever Medications in Asthma Management: Evidence-Based Science
por: Amirav, Israel, et al.
Publicado: (2023) -
Manifesto on the overuse of SABA in the management of asthma: new
approaches and new strategies
por: Canonica, Giorgio Walter, et al.
Publicado: (2021) -
Asthma and COVID-19: In Defense of Evidence-Based SABA
por: Amirav, Israel, et al.
Publicado: (2020)